Clinical Trial Update: MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial of MRG006A in combination therapy for advanced hepatocellular carcinoma; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MRG006A

Snippet

Sponsor: Lepu Biopharma Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING